These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2304290)

  • 1. The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF).
    Katano M; Mizoguchi T; Yamamoto H; Nakamura M; Matsuo T; Hisatugu T; Kisu T; Yamaoka K; Tokunaga O
    Jpn J Surg; 1990 Jan; 20(1):76-82. PubMed ID: 2304290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.
    Katano M; Yamamoto H; Mizoguchi T; Hisatsugu T
    Cancer Immunol Immunother; 1988; 27(3):198-204. PubMed ID: 3141056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy.
    Katano M; Kubota E; Yamamoto H; Nakamura M; Matsuo T; Hisatsugu T; Katsuki T; Koga H; Ikezaki K; Tabuchi K
    Biotherapy; 1991; 3(4):373-9. PubMed ID: 1786201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumoricidal effect of human PBMC following stimulation with OK-432 and its application for locoregional immunotherapy in head and neck cancer patients.
    Kubota E; Katano M; Kurokawa H; Imamura H; Katsuki T; Yamamoto H; Hisatsugu T; Nagumo F; Tadano J
    J Craniomaxillofac Surg; 1993 Jan; 21(1):30-7. PubMed ID: 8445052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of TGIF and interferon gamma (IFN-gamma) on tumor cell growth. TGIF and IFN-gamma.
    Katano M; Yamamoto H; Nakamura M; Matsuo T; Hisatsugu T
    Biotherapy; 1990; 2(1):33-40. PubMed ID: 2119202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
    Kaji R; Yoshida H; Yanagawa T; Sato M
    J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intratumor injection of OK-432-stimulated peripheral blood mononuclear cells: a significance of mononuclear cell-producing tumor inhibitory factor induced by OK-432].
    Mizoguchi T; Katano M; Yamamoto H; Hisatsugu T
    Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):794. PubMed ID: 3627102
    [No Abstract]   [Full Text] [Related]  

  • 8. The endoscopic intratumor administration of OK-432 in gastric cancer unsuitable for surgery.
    Nakazawa S; Yoshino J; Kijima Y; Yasumasa N; Ohhashi S; Mizutani K
    Endoscopy; 1989 Jul; 21(4):168-71. PubMed ID: 2776702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432].
    Neda H; Watanabe N; Sone H; Yamauchi N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
    Katano M; Mizoguchi T; Yamamoto H; Hisatsugu T; Torisu M
    Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].
    Satomi T; Inoue S; Fujita T; Ogawa S; Honda H; Hayashi M
    Gan No Rinsho; 1989 Mar; 35(4):512-5. PubMed ID: 2541269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful adoptive immunotherapy with OK432-inducible activated natural killer cells in tumor-bearing mice.
    Yamaue H; Tanimura H; Iwahashi M; Tsunoda T; Tani M; Inoue M
    Biotherapy; 1990; 2(1):51-61. PubMed ID: 2400628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of OK 432 upon postoperative alteration in activities producing lymphokines, IL 1, IL 2, and IFN, of peripheral blood mononuclear cells derived from patients with gastric cancer].
    Hosoi J
    Nihon Gan Chiryo Gakkai Shi; 1987 Apr; 22(3):603-13. PubMed ID: 2443588
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of unresectable advanced gastric cancer with effective treatment by local administration of OK-432 on operation].
    Kodama M; Taniguchi T; Furukawa H; Takahashi T; Hara T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2301-3. PubMed ID: 2735772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
    Hanaue H; Nomoto S; Kimura T; Kutsuna T; Takeuchi T; Yoshizaki S
    Keio J Med; 1982 Dec; 31(4):159-68. PubMed ID: 6985379
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer].
    Nio Y; Tobe T
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1436-8. PubMed ID: 2586435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
    Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
    J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
    Mori H; Itoh N; Tamaya T
    Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.